Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 127

2.

Antibody therapy for Lassa fever.

Cross RW, Hastie KM, Mire CE, Robinson JE, Geisbert TW, Branco LM, Ollmann Saphire E, Garry RF.

Curr Opin Virol. 2019 Aug 8;37:97-104. doi: 10.1016/j.coviro.2019.07.003. [Epub ahead of print] Review.

PMID:
31401518
3.

Convergent Structures Illuminate Features for Germline Antibody Binding and Pan-Lassa Virus Neutralization.

Hastie KM, Cross RW, Harkins SS, Zandonatti MA, Koval AP, Heinrich ML, Rowland MM, Robinson JE, Geisbert TW, Garry RF, Branco LM, Saphire EO.

Cell. 2019 Aug 8;178(4):1004-1015.e14. doi: 10.1016/j.cell.2019.07.020.

PMID:
31398326
4.

Machine-learning Prognostic Models from the 2014-16 Ebola Outbreak: Data-harmonization Challenges, Validation Strategies, and mHealth Applications.

Colubri A, Hartley MA, Siakor M, Wolfman V, Felix A, Sesay T, Shaffer JG, Garry RF, Grant DS, Levine AC, Sabeti PC.

EClinicalMedicine. 2019 Jun 22;11:54-64. doi: 10.1016/j.eclinm.2019.06.003. eCollection 2019 May-Jun.

5.

Survivors of Ebola virus disease develop polyfunctional antibody responses.

Gunn BM, Roy V, Karim MM, Hartnett JN, Suscovich TJ, Goba A, Momoh M, Sandi JD, Kanneh L, Andersen KG, Shaffer JG, Schieffelin JS, Garry RF, Grant DS, Alter G.

J Infect Dis. 2019 Jul 12. pii: jiz364. doi: 10.1093/infdis/jiz364. [Epub ahead of print]

PMID:
31301137
6.

A medical records and data capture and management system for Lassa fever in Sierra Leone: Approach, implementation, and challenges.

Shaffer JG, Schieffelin JS, Gbakie M, Alhasan F, Roberts NB, Goba A, Randazzo J, Momoh M, Moon TD, Kanneh L, Levy DC, Podgorski RM, Hartnett JN, Boisen ML, Branco LM, Samuels R, Grant DS, Garry RF; Viral Hemorrhagic Fever Consortium.

PLoS One. 2019 Mar 28;14(3):e0214284. doi: 10.1371/journal.pone.0214284. eCollection 2019.

7.

Data set on Lassa fever in post-conflict Sierra Leone.

Shaffer JG, Schieffelin JS, Grant DS, Goba A, Momoh M, Kanneh L, Levy DC, Hartnett JN, Boisen ML, Branco LM, Garry RF; Viral Hemorrhagic Fever Consortium.

Data Brief. 2019 Jan 16;23:103673. doi: 10.1016/j.dib.2019.01.021. eCollection 2019 Apr.

8.

2018 international meeting of the Global Virus Network.

Brechot C, Bryant J, Endtz H, Garry RF, Griffin DE, Lewin SR, Mercer N, Osterhaus A, Picot V, Vahlne A, Verjans GMGM, Weaver S.

Antiviral Res. 2019 Mar;163:140-148. doi: 10.1016/j.antiviral.2019.01.013. Epub 2019 Jan 25. Review.

PMID:
30690044
9.

Host Proteins Identified in Extracellular Viral Particles as Targets for Broad-Spectrum Antiviral Inhibitors.

Gale TV, Horton TM, Hoffmann AR, Branco LM, Garry RF.

J Proteome Res. 2019 Jan 4;18(1):7-17. doi: 10.1021/acs.jproteome.8b00204. Epub 2018 Nov 5.

PMID:
30351952
10.

Genomic Analysis of Lassa Virus during an Increase in Cases in Nigeria in 2018.

Siddle KJ, Eromon P, Barnes KG, Mehta S, Oguzie JU, Odia I, Schaffner SF, Winnicki SM, Shah RR, Qu J, Wohl S, Brehio P, Iruolagbe C, Aiyepada J, Uyigue E, Akhilomen P, Okonofua G, Ye S, Kayode T, Ajogbasile F, Uwanibe J, Gaye A, Momoh M, Chak B, Kotliar D, Carter A, Gladden-Young A, Freije CA, Omoregie O, Osiemi B, Muoebonam EB, Airende M, Enigbe R, Ebo B, Nosamiefan I, Oluniyi P, Nekoui M, Ogbaini-Emovon E, Garry RF, Andersen KG, Park DJ, Yozwiak NL, Akpede G, Ihekweazu C, Tomori O, Okogbenin S, Folarin OA, Okokhere PO, MacInnis BL, Sabeti PC, Happi CT.

N Engl J Med. 2018 Nov 1;379(18):1745-1753. doi: 10.1056/NEJMoa1804498. Epub 2018 Oct 17.

11.

Ebola Mysteries and Conundrums.

Garry RF.

J Infect Dis. 2019 Jan 29;219(4):511-513. doi: 10.1093/infdis/jiy476. No abstract available.

PMID:
30085161
12.

Analysis of CD8+ T cell response during the 2013-2016 Ebola epidemic in West Africa.

Sakabe S, Sullivan BM, Hartnett JN, Robles-Sikisaka R, Gangavarapu K, Cubitt B, Ware BC, Kotliar D, Branco LM, Goba A, Momoh M, Sandi JD, Kanneh L, Grant DS, Garry RF, Andersen KG, de la Torre JC, Sabeti PC, Schieffelin JS, Oldstone MBA.

Proc Natl Acad Sci U S A. 2018 Aug 7;115(32):E7578-E7586. doi: 10.1073/pnas.1806200115. Epub 2018 Jul 23.

13.

Early detection of Lassa fever: the need for point-of-care diagnostics.

Dhillon RS, Srikrishna D, Garry RF.

Lancet Infect Dis. 2018 Jun;18(6):601-602. doi: 10.1016/S1473-3099(18)30277-9. No abstract available.

PMID:
29856352
14.

Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever.

Boisen ML, Hartnett JN, Shaffer JG, Goba A, Momoh M, Sandi JD, Fullah M, Nelson DKS, Bush DJ, Rowland MM, Heinrich ML, Koval AP, Cross RW, Barnes KG, Lachenauer AE, Lin AE, Nekoui M, Kotliar D, Winnicki SM, Siddle KJ, Gbakie M, Fonnie M, Koroma VJ, Kanneh L, Kulakosky PC, Hastie KM, Wilson RB, Andersen KG, Folarin OO, Happi CT, Sabeti PC, Geisbert TW, Saphire EO, Khan SH, Grant DS, Schieffelin JS, Branco LM, Garry RF.

Sci Rep. 2018 Apr 12;8(1):5939. doi: 10.1038/s41598-018-24246-w.

15.

Ebola Virus Persistence in Ocular Tissues and Fluids (EVICT) Study: Reverse Transcription-Polymerase Chain Reaction and Cataract Surgery Outcomes of Ebola Survivors in Sierra Leone.

Shantha JG, Mattia JG, Goba A, Barnes KG, Ebrahim FK, Kraft CS, Hayek BR, Hartnett JN, Shaffer JG, Schieffelin JS, Sandi JD, Momoh M, Jalloh S, Grant DS, Dierberg K, Chang J, Mishra S, Chan AK, Fowler R, O'Dempsey T, Kaluma E, Hendricks T, Reiners R, Reiners M, Gess LA, ONeill K, Kamara S, Wurie A, Mansaray M, Acharya NR, Liu WJ, Bavari S, Palacios G, Teshome M, Crozier I, Farmer PE, Uyeki TM, Bausch DG, Garry RF, Vandy MJ, Yeh S.

EBioMedicine. 2018 Apr;30:217-224. doi: 10.1016/j.ebiom.2018.03.020. Epub 2018 Mar 23.

16.

Metabolomics analyses identify platelet activating factors and heme breakdown products as Lassa fever biomarkers.

Gale TV, Horton TM, Grant DS, Garry RF.

PLoS Negl Trop Dis. 2017 Sep 18;11(9):e0005943. doi: 10.1371/journal.pntd.0005943. eCollection 2017 Sep.

17.

Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever.

Mire CE, Cross RW, Geisbert JB, Borisevich V, Agans KN, Deer DJ, Heinrich ML, Rowland MM, Goba A, Momoh M, Boisen ML, Grant DS, Fullah M, Khan SH, Fenton KA, Robinson JE, Branco LM, Garry RF, Geisbert TW.

Nat Med. 2017 Oct;23(10):1146-1149. doi: 10.1038/nm.4396. Epub 2017 Sep 4.

18.

Structural basis for antibody-mediated neutralization of Lassa virus.

Hastie KM, Zandonatti MA, Kleinfelter LM, Heinrich ML, Rowland MM, Chandran K, Branco LM, Robinson JE, Garry RF, Saphire EO.

Science. 2017 Jun 2;356(6341):923-928. doi: 10.1126/science.aam7260.

19.

Ebola Virus Delta Peptide Is a Viroporin.

He J, Melnik LI, Komin A, Wiedman G, Fuselier T, Morris CF, Starr CG, Searson PC, Gallaher WR, Hristova K, Garry RF, Wimley WC.

J Virol. 2017 Jul 27;91(16). pii: e00438-17. doi: 10.1128/JVI.00438-17. Print 2017 Aug 15.

20.

Genomic epidemiology reveals multiple introductions of Zika virus into the United States.

Grubaugh ND, Ladner JT, Kraemer MUG, Dudas G, Tan AL, Gangavarapu K, Wiley MR, White S, Thézé J, Magnani DM, Prieto K, Reyes D, Bingham AM, Paul LM, Robles-Sikisaka R, Oliveira G, Pronty D, Barcellona CM, Metsky HC, Baniecki ML, Barnes KG, Chak B, Freije CA, Gladden-Young A, Gnirke A, Luo C, MacInnis B, Matranga CB, Park DJ, Qu J, Schaffner SF, Tomkins-Tinch C, West KL, Winnicki SM, Wohl S, Yozwiak NL, Quick J, Fauver JR, Khan K, Brent SE, Reiner RC Jr, Lichtenberger PN, Ricciardi MJ, Bailey VK, Watkins DI, Cone MR, Kopp EW 4th, Hogan KN, Cannons AC, Jean R, Monaghan AJ, Garry RF, Loman NJ, Faria NR, Porcelli MC, Vasquez C, Nagle ER, Cummings DAT, Stanek D, Rambaut A, Sanchez-Lockhart M, Sabeti PC, Gillis LD, Michael SF, Bedford T, Pybus OG, Isern S, Palacios G, Andersen KG.

Nature. 2017 Jun 15;546(7658):401-405. doi: 10.1038/nature22400. Epub 2017 May 24.

Supplemental Content

Loading ...
Support Center